Free shipping over €250 · Tracked, discreet delivery in Europe

Oral MC1R agonist

Dersimelagon

MT-7117

In clinical trialsNot yet reviewedSmall molecule

In short: An oral small-molecule MC1 receptor agonist. In clinical trials for erythropoietic protoporphyria.

Regulatory status

  1. Cosmetic ingredient
  2. Research compound
  3. In clinical trials
  4. Approved medicine

In human clinical trials and not yet approved by the FDA or the EMA. Results to date are from trial populations under medical supervision.

A full research summary for this compound has not been published in the library yet. The status and class above are current.

Common questions

Is Dersimelagon an approved medicine?

In clinical trials. In human clinical trials and not yet approved by the FDA or the EMA. Results to date are from trial populations under medical supervision.

How much human research is there on Dersimelagon?

A full research summary for this compound has not been published in the library yet. The status and class above are current.

Does UU supply Dersimelagon?

No. It appears in the library for reference only, so the field can be read in one place.

More in Skin & hair

Back to the library
  • Cosmeticuu

    GHK-Cu

    Copper tripeptide

    Mixed evidence
  • Researchuu

    Glutathione

    Antioxidant tripeptide

    Early human data
  • Approveduu

    Afamelanotide

    Melanocortin agonist

    Human trials
  • Researchuu

    LL-37

    Antimicrobial peptide

    Early human data
  • Cosmeticuu

    AHK-Cu

    Copper tripeptide

    Not yet reviewed
  • Cosmeticuu

    SNAP-8

    SNARE-mimicking peptide

    Not yet reviewed

The UU library is an educational reference. It is not medical advice, does not make a health claim, and does not tell anyone how to use a compound. UU products are sold for laboratory research use only and are not for human consumption. Regulatory status changes: confirm it with the relevant authority before relying on it.